Adalimumab vs Levodopa

## Adalimumab vs Levodopa: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Levodopa**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Levodopa — 1.5 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Levodopa — C9H11NO4.

**Molecular Weight**: Adalimumab — N/A; Levodopa — 197.1880 g/mol.

**Type**: Adalimumab — Antibody; Levodopa — Small molecule.